For many years people have been fighting in different places on this earth to get marijuana legalized. This plant has been a topic of discussion for as long as human kind can remember and still is today. Every year billions of dollars get spent on both campaigning for legalization as well as criminalization, but there was always Amsterdam; The capital of The Netherlands, city of Sodom and Gomorrah, a place where prostitution and drugs are decriminalized and maintained by both government and people. But all this might be about to change and 2012 could be the last year for foreigners to visit Amsterdam and being able to visit one of the many cannabis café’s as the government is planning to change the laws on cannabis.
Although The Netherlands host more than 600 cannabis café’s or coffeeshops as they call them, cannabis has never been 100% legal. Since the 70’s the government has had a policy of tolerance regarding cannabis. Soft drugs, as they call them, are available to any adult person. It is allowed to purchase up to 5 grams of cannabis in a coffeeshop or to carry around. Also growing up to 5 plants is kind of tolerated, although any kind of professional growing is illegal. This means that even putting a light on a plant to help it grow is considered illegal and if the police would actually find any plants at a person’s house they will probably seize them.
The strange thing about the Dutch policy is that it apparently is legal to professionally sell cannabis, but illegal to professionally grow cannabis. A coffeeshop is allowed to have up to 500 grams of cannabis in the establishment but on a good day they can sell a lot more than that. Some coffeeshops can sell even more than 10 kilograms of cannabis each day so where does all this cannabis come from if it illegal to be grown?
Each year the government busts more than 6000 illegal plantations all over the country, from small rooms where cannabis is being grown in closets to huge plantations where thousands of plants are being grown. Various cannabis seeds can legally bought in shops. Hundreds of headshops and growshops are selling anything you need to grow cannabis, but the government will probably never tolerate growing.
For years there have been rumors that the Dutch government wants to ban cannabis completely just like how in 2008 magic mushrooms were banned and put on the list of illegal drugs. Until 2007 it was possible and legal to buy magic mushrooms in smartshops, but after a few incidents involving tourists who supposedly consumed mushrooms, the government banned this product of nature. Of course a lot of people protest against this decision as some of the mushrooms that were being put on the black list actually grow in the wild in the Netherlands. Also it was later proved that the incidents that had been taken as an excuse to ban mushrooms, involved tourists that had been consuming various other drugs like cocaine and were drinking alcohol at the time as well. As a result, many people are buying ready to grow magic mushroom grow kits or mushroom spores to grow their own magic mushrooms, a procedure that is fairly simple.
The whole idea to make coffeeshop unavailable for tourists has been widely criticized in the media. The new law went in to effect in the South of the country in the beginning of March this year and has resulted in many problems. Not only the coffeeshops lost customers, but also other shops and even the local McDonalds complaint that they have lost a big amount of customers. The streets of the city of Maastricht, a city in the South which is very close to both Belgium and Germany, have been flooded with illegal street dealers that are selling cannabis to tourists. The local authority doesn’t really seem to know how to handle this change good as well and although the mayor of the city has been the only one that kept saying that things were going as planned; he now also finally admitted that the new law doesn’t work and that the government should turn it back.
The new law is supposed to go in effect in the rest of the country including Amsterdam from the 1st of January 2013.
This video is the first to reveal the background origins of the Esalen institute through Aldous and Julian Huxley, both grandson’s of Charles Darwin’s “Bulldog” Sir. Thomas Henry Huxley. The Huxleys helped found the Esalen institute to promote Julian Huxley’s eugenics, humanism, transhumanism and feminism to manipulate middle class Americans into following their agenda through psychedelics and the new age movement.
This is not to say that psychedelics or entheogens don’t have value, it just means that devious people have usurped them and created a false movement to fool people into thinking that they’ve completed their task of freeing their minds.
As McKenna says in one quote found shortly after we film this video:
“This was in ’67 when I was a sophomore in college. The interest in altered states of consciousness came simply from, I don’t know whether I was a precocious kid or what, but I was very early into the New York literary scene, and even though I lived in a small town in Colorado, I subscribed to the Village Voice, and there I encountered propaganda about LSD, mescaline, and all these experiments that the late beatniks were involved in. Then I read The Doors of Perception and Heaven and Hell, and it just rolled from there. That was what really put me over. ***I respected Huxley as a novelist, and I was slowly reading everything he’d ever written, and when I got to The Doors of Perception I said to myself, “There’s something going on here for sure.***”
~ Terence McKenna – From Mushrooms, Elves, and Magic.
Horizons Conference to Present New Research on the Medical and Psychological Use of Psychedelic Drugs Speakers to address use of psychedelics to treat hard drug addiction, terminal cancer anxiety disorder, post-traumatic stress disorder, and other intractable illnesses
New York, NY (October 12, 2012)– The sixth annual “Horizons: Perspectives on Psychedelics” conference is to be held at Judson Memorial Church on NYU campus in NYC on October 12-14. Horizons focuses on contemporary research into the clinical applications of psychedelics, providing an invaluable forum for experts to share ideas, insights, and to rethink the role of psychedelics in science, medicine, art, culture, and spirituality.
Speakers include medical researchers from NYU, UCLA, Hebrew University and other prestigious institutions, world-renown artists, spiritual scholars, bestselling authors, and other key players.
This year’s presentations include:
“Seeing with the Eyes Shut: Neural Basis of Enhanced Visual Imagery following
Sidarta Ribeiro, Ph.D., Director, Brain Institute, Federal University of Rio Grande Do Norte, Brazil
“The Rule of Three from NYU: (1) A patient speaks, (2) A proposed narrative study of patient experiences, and (3) Recent findings from the NYU Psilocybin Cancer Anxiety Study,”
Alexander Belser, NYU
“MDMA-Assisted Psychotherapy for PTSD Research: Bridging Biology and Psychology” Amy Emerson, Director of Clinical Research, Multidisciplinary Association for Psychedelic studies
“Why Psychedelics Matter,”
Charles S. Grob, M.D, Professor of Psychiatry and Pediatrics at the UCLA School of Medicine, Director of the Division of Child and Adolescent Psychiatry at the Harbor-UCLA Medical Center
“Amazonian Grass Roots Research on Entheogen-based healing of Physical Pathologies,” Roman Hanis, Director of Paititi Institute of Iquitos, Peru
Cristina Sanchez, a young biologist at Complutense University in Madrid, was studying cell metabolism when she noticed something peculiar. She had been screening brain cancer cells because they grow faster than normal cell lines and thus are useful for research purposes. But the cancer cells died each time they were exposed to tetrahydrocannabinol (THC), the principal psychoactive ingredient of marijuana.
Instead of gaining insight into how cells function, Sanchez had stumbled upon the anti-cancer properties of THC. In 1998, she reported in a European biochemistry journal that THC “induces apoptosis [cell death] in C6 glioma cells,” an aggressive form of brain cancer.
Subsequent peer-reviewed studies in several countries would show that THC and other marijuana-derived compounds, known as “cannabinoids,” are effective not only for cancer-symptom management (nausea, pain, loss of appetite, fatigue), they also confer a direct antitumoral effect.
A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. Guzman administered pure THC via a catheter into the tumors of nine hospitalized patients with glioblastoma, who had failed to respond to standard brain-cancer therapies. The results were published in 2006 in the British Journal of Pharmacology: THC treatment was associated with significantly reduced tumor cell proliferation in every test subject.
Around the same time, Harvard University scientists ++reported++[http://www.nature.com/bjc/journal/v95/n2/abs/6603236a.html] that THC slows tumor growth in common lung cancer and “significantly reduces the ability of the cancer to spread.” What’s more, like a heat-seeking missile, THC selectively targets and destroys tumor cells while leaving healthy cells unscathed.
Aric Crabb, Bay Area News Group / AP Photos
There is mounting evidence, according to a report in Mini-Reviews in Medicinal Chemistry, that cannabinoids “represent a new class of anticancer drugs that retard cancer growth, inhibit angiogenesis [the formation of new blood cells that feed a tumor] and the metastatic spreading of cancer cells.”
Dr. Sean McAllister, a scientist at the Pacific Medical Center in San Francisco, has been studying cannabinoid compounds for 10 years in a quest to develop new therapeutic interventions for various cancers. Backed by grants from the National Institute of Health (and with a license from the DEA), McAllister discovered that cannabidiol (CBD), a nonpsychoactive component of the marijuana plant, is a potent inhibitor of breast cancer cell proliferation, metastasis, and tumor growth. In 2007, McAllister published a detailed account of how cannabidiol kills breast cancer cells and destroys malignant tumors by switching off expression of the ID-1 gene, a protein that appears to play a major role as a cancer cell conductor.